Compare BDSX & NREF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BDSX | NREF |
|---|---|---|
| Founded | 2005 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precision Instruments | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 276.2M | 296.5M |
| IPO Year | 2020 | N/A |
| Metric | BDSX | NREF |
|---|---|---|
| Price | $27.30 | $15.55 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 3 |
| Target Price | ★ $37.33 | $16.75 |
| AVG Volume (30 Days) | ★ 87.9K | 71.4K |
| Earning Date | 11-02-2026 | 10-29-2026 |
| Dividend Yield | N/A | ★ 12.65% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $88,499,000.00 | N/A |
| Revenue This Year | $26.51 | N/A |
| Revenue Next Year | $20.25 | $5.04 |
| P/E Ratio | ★ N/A | $4.78 |
| Revenue Growth | ★ 24.08 | N/A |
| 52 Week Low | $5.26 | $12.36 |
| 52 Week High | $31.97 | $18.43 |
| Indicator | BDSX | NREF |
|---|---|---|
| Relative Strength Index (RSI) | 49.10 | 38.66 |
| Support Level | $19.26 | $14.45 |
| Resistance Level | $31.31 | $16.09 |
| Average True Range (ATR) | 2.01 | 0.49 |
| MACD | -0.27 | -0.07 |
| Stochastic Oscillator | 19.15 | 29.93 |
Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.
NexPoint Real Estate Finance Inc is a commercial mortgage REIT focused on generating attractive, risk-adjusted returns for shareholders over the long term. The company invests mainly in first-lien mortgage loans, mezzanine loans, preferred equity, multifamily properties, and common equity investments, as well as multifamily and single-family rental CMBS securitizations, promissory notes, revolving credit facilities, and stock warrants. It focuses on real estate sectors where its management has operating expertise, including multifamily, single-family rental, self-storage, industrial, and life sciences, mainly in top metropolitan areas.